<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0017921" disease_type="Disease or Syndrome" abbrv="AMD">Pompe disease</z:e> is an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> disorder caused by lysosomal acid α-glucosidase deficiency </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003593'>Infantile-onset</z:hpo> <z:e sem="disease" ids="C0017921" disease_type="Disease or Syndrome" abbrv="AMD">Pompe disease</z:e> presents with <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and <z:mp ids='MP_0004144'>hypotonia</z:mp>, leading to premature <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This article describes 7 infantile <z:e sem="disease" ids="C0017921" disease_type="Disease or Syndrome" abbrv="AMD">Pompe disease</z:e> cases and provides their molecular bases and clinical outcomes after enzyme replacement therapy for the first time in Korea </plain></SENT>
<SENT sid="3" pm="."><plain>Molecular genetic analyses revealed the presence of 9 different mutations, including 5 novel mutations (c.2171C&gt;A, c.2774C&gt;T, c.1582_3de12, c.1261_1263Tms, and c.1322_1326+9de114) </plain></SENT>
<SENT sid="4" pm="."><plain>The most common mutation in these 7 patients was c.1316T&gt;A (28%) </plain></SENT>
<SENT sid="5" pm="."><plain>Four patients received intravenous recombinant human acid α-glucosidase therapy for 2 years, on average, without significant side effects during the treatment course </plain></SENT>
<SENT sid="6" pm="."><plain>They <z:hpo ids='HP_0000001'>all</z:hpo> exhibited increased muscle power, with considerable improvement in cardiac function </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0017921" disease_type="Disease or Syndrome" abbrv="AMD">Pompe disease</z:e> is <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> regarding both clinical features and molecular characteristics </plain></SENT>
<SENT sid="8" pm="."><plain>Early identification of <z:e sem="disease" ids="C0017921" disease_type="Disease or Syndrome" abbrv="AMD">Pompe disease</z:e> is very important, considering that enzyme replacement therapy is a safe and effective treatment for early-<z:hpo ids='HP_0003674'>onset</z:hpo> patients </plain></SENT>
</text></document>